文献速递主动脉疾病

EVAR术后初始瘤囊回缩的预后价值

Prognostic Value of Initial Aneurysmal Sac Regression after EVAR.
PubMed 文献 · Ann Vasc Surg · 2019-10-16

该回顾性队列研究纳入128例择期EVAR患者,按术后1年瘤囊是否回缩分为A组(回缩)和B组(稳定)。A组随访期内内漏发生率更低(31.4% vs 74%,P<0.001),5年无增长率和无再干预率均更高,提示初始瘤囊回缩预示良好转归。

要点

  • EVAR术后1年瘤囊回缩者随访内漏更少、瘤囊增长更少。
  • 初始瘤囊回缩者5年无增长率和无再干预率更高。
  • 初始瘤囊回缩或可支持调整随访方案,包括II型内漏者。

核心结论

  • EVAR术后初始瘤囊回缩者随访中瘤囊转归更佳,内漏更少、增长更少。

研究设计与样本

  • 回顾性队列研究,纳入2005年1月至2014年12月择期EVAR患者,随访至少18个月,共128例。

主要发现

  • A组随访期内漏发生率低于B组(31.4% vs 74%,P<0.001)。
  • 所有瘤囊增长均与内漏相关。
  • 术后5年A组无增长率为96.9%,B组为85.2%(HR 4.8,95%CI 1.1-21.4,P=0.036)。
  • A组无因II型内漏而再手术者。

关键数值与推荐

  • A组术前动脉瘤直径更大(63.5 mm vs 59.25 mm,P=0.048)。
  • A组后壁血栓更常见(68.6% vs 30.7%,P<0.001),通畅腰动脉更少(56.9% vs 83.1%,P=0.001)。

临床怎么用

  • EVAR术后1年瘤囊回缩可视为良好预后标志,或可据此调整随访强度。
  • 即使存在II型内漏,初始瘤囊回缩者随访中亦可能无需积极再干预。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of the study was to evaluate the impact of initial aneurysmal sac reduction after endovascular aneurysm repair on the evolution of aneurysmal sac over follow-up. METHODS: A retrospective cohort study was made of patients subjected to elective treatment between January 2005 and December 2014, with a minimum follow-up of 18 months. An analysis was made of the evolution of the aneurysmal sac according to its condition one year after surgery, defining of two groups: A (sac reduction) and B (stable sac). Follow-up by computed tomography (CT) angiography was made after one month and then every 6 months or annually, depending on the presence of endoleak. RESULTS: A total of 128 patients were included. Fifty-one patients (39.8%) showed a significant decrease in diameter during the first year (group A), whereas 77 patients (60.2%) showed no initial decrease (group B). Preoperative CT angiography showed the patients in group A to have larger aneurysms (63.5 mm vs. 59.25; P = 0.048), a greater presence of posterior thrombus (68.6% vs. 30.7%; P < 0.001), and fewer patent lumbar vessels (56.9% vs. 83.1%; P = 0.001). The prevalence of endoleak at some point during follow-up was lower in group A (31.4% vs. 74% in group B; P < 0.001), and 100% of all aneurysmal growths were associated to the presence of endoleak. After 5 years, significant differences were observed in the growth-free rate (96.9% in group A vs. 85.2% in group B; hazard ratio [HR] 4.8 [1.1-21.4; P = 0.036]) and in the reintervention-free rate (95,7% vs. 84.6%; HR 6.6 [0.8-52.4; P = 0.07]). No reoperation in group A was due to type II endoleak. CONCLUSIONS: The aneurysmal sac can be expected to take a favorable course in those cases characterized by initial aneurysmal sac reduction. These findings may imply a change in the follow-up protocol, even in cases with type II endoleak.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Plá Sánchez F, Martínez López I, Hernández Mateo MM, et al. Prognostic Value of Initial Aneurysmal Sac Regression after EVAR. Ann Vasc Surg. 2019. PMID: 31629125. doi:10.1016/j.avsg.2019.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。